ARCHIVES

Univ. of Rochester Leads Trial Of Combination Chemotherapy For Pancreatic Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

August 19, 1994

Abstracts of Papers From ASCO Meeting

April 14, 1978

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

Intercultural Cancer Council Endorses New NCI Office

July 5, 1996

Also in this 8-page issue: NCI, FDA open Web site for adverse event reporting.

April 16, 2004

In Brief: Robert Young Named President Of Fox Chase; Elion, Hitchings Share Nobel Prize With Birton

October 21, 1988